Condition: Asthma · Sponsor: Sally E. Wenzel MD
Single center, randomized, placebo- controlled study to assess change in mucociliary clearance of moderate to severe asthma patients after treatment with dupilumab or placebo.
This description comes directly from the study's public registry record.
John Moore · 412-648-6726 · mooreja6@upmc.edu
Always discuss trial participation with your own doctor first.
| The University of Pittsburgh Asthma Institute at UPMC | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04743791